Lunch and Learn: About the NHS Cancer Vaccine Launch Pad (CVLP)

The CVLP is a platform facilitating patient access to clinical trials of personalised cancer vaccine treatment. Patients will be asked to consent to be put forward for trials and surplus tissue samples, obtained through standard of care pathways, will be used to assess their eligibility for current or future cancer vaccine trials run by trial sponsors. The details of any available trials will be shared with the participant and their local treating clinical team, to see if they would consider taking part in the trial(s) for which they are eligible and to facilitate this if so.

 The first trial sponsor to work with the CVLP is BioNTech SE, with their BNT122-01 cancer vaccine trial in colorectal cancer patients. Further trial sponsors, with new cancer vaccines across a broad range of cancer types are expected to come on board in late 2024.

 The CVLP is a collaborative project led by NHS England (NHSE) together with Genomics England, the Department of Health and Social Care, the Office for Life Sciences, and the National Institute for Health and Care Research with involvement of the Cancer Research UK Southampton Clinical Trials Unit.

 For more details about the CVLP, please visit https://www.england.nhs.uk/cancer/nhs-cancer-vaccine-launch-pad/the and https://www.southampton.ac.uk/ctu/cancer-vaccine-launch-pad.page.

 About this event

 Join us at this webinar, brought to you by NHS England and Southampton Clinical Trials Unit to hear more about the NHS CVLP with a particular focus in pathology. You will take away a range of examples and ideas on how pathology plays an important role in cancer vaccine research. We will also share our learning on progress, celebrate our achievement so far and tell you more how you could get involved in the CVLP as a pathologist. In this webinar, you will also be able to find out the development of long term approach and the potential for the next phase of the CVLP.

 This webinar aims to foster knowledge exchange and galvanize collaboration across the system with opportunities for you to share your feedback and ask questions.  

 Who should attend

 This webinar welcomes all pathology colleagues in the NHS with an interest and/or subject matter expertise in cancer vaccine research, including trainees.

Questions about this event?

Name: Hardeep Basan

Email: h.basan@nhs.net

Telephone: N/A.................